ResMed Inc. (RMD) Ownership
RMD ownership summary
as of October 18, 2026- Institutions
- 73.0% of shares outstanding
- Insiders
- 0.51% of shares outstanding
- Shares outstanding
- 140.6M
- Float
- 143.3M shares available to trade
- Short interest
- 9.13% 12.8M shares short
- Days to cover
- 10.02 short interest down 2.2% vs prior month
- Institutions 72.95%
- Insiders 0.51%
- Other investors 26.54%
RMD top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 8.76% | 12.3M | $2.94B | +223,171 (+1.8%) | June 30, 2026 |
| 2 | Vanguard Capital Management, LLC | 6.74% | 9.5M | $2.26B | +7,713 (+0.1%) | June 30, 2026 |
| 3 | Vanguard Portfolio Management, LLC | 5.63% | 7.9M | $1.89B | +49,739 (+0.6%) | June 30, 2026 |
| 4 | State Street Corp | 4.75% | 6.7M | $1.60B | +37,567 (+0.6%) | June 30, 2026 |
| 5 | Geode Capital Management, LLC | 3.09% | 4.4M | $1.04B | −553 (−0.0%) | June 30, 2026 |
| 6 | Bank of New York Mellon Corp | 2.98% | 4.2M | $1.00B | −727,776 (−14.8%) | June 30, 2026 |
| 7 | First Trust Advisors L.P. | 1.62% | 2.3M | $544.5M | +740,871 (+48.2%) | June 30, 2026 |
| 8 | Amvescap Plc. | 1.47% | 2.1M | $493.1M | +106,964 (+5.5%) | June 30, 2026 |
| 9 | Morgan Stanley - Brokerage Accounts | 1.37% | 1.9M | $461.0M | −757,890 (−28.2%) | June 30, 2026 |
| 10 | Northern Trust Corp | 1.21% | 1.7M | $405.5M | −29,019 (−1.7%) | June 30, 2026 |
| 11 | Nordea Investment Mgmt Bank Demark A/s | 0.99% | 1.4M | $331.7M | +354,627 (+34.3%) | June 30, 2026 |
| 12 | Deutsche Bank AG | 0.94% | 1.3M | $316.0M | −100,552 (−7.1%) | June 30, 2026 |
| 13 | UBS Group AG | 0.92% | 1.3M | $308.1M | +562,489 (+77.4%) | June 30, 2026 |
| 14 | Swedbank AB | 0.91% | 1.3M | $304.7M | −75,337 (−5.6%) | June 30, 2026 |
| 15 | Charles Schwab Investment Management Inc | 0.87% | 1.2M | $292.1M | +87,174 (+7.7%) | June 30, 2026 |
| 16 | The Goldman Sachs Group Inc | 0.83% | 1.2M | $277.3M | +156,221 (+15.6%) | June 30, 2026 |
| 17 | Arrowstreet Capital Limited Partnership | 0.80% | 1.1M | $270.0M | +679,489 (+150.9%) | June 30, 2026 |
| 18 | Dimensional Fund Advisors, Inc. | 0.80% | 1.1M | $268.5M | +119,359 (+11.9%) | June 30, 2026 |
| 19 | Legal & General Group PLC | 0.67% | 943K | $225.3M | −47,747 (−4.8%) | June 30, 2026 |
| 20 | AQR Capital Management LLC | 0.65% | 911K | $217.6M | +560,783 (+160.3%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 13 holders added 3.7M shares and 7 cut 1.7M.
RMD top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 3.28% | 4.6M | $1.10B | −9,477 (−0.2%) | August 31, 2026 |
| 2 | Vanguard 500 Index Investor | 2.69% | 3.8M | $905.5M | −64,579 (−1.7%) | September 30, 2026 |
| 3 | Vanguard MStar Mid Cap Index Instl | 2.20% | 3.1M | $738.2M | −48,739 (−1.6%) | September 30, 2026 |
| 4 | iShares Core S&P 500 ETF | 1.37% | 1.9M | $459.4M | −3,108 (−0.2%) | September 30, 2026 |
| 5 | Fidelity 500 Index | 1.34% | 1.9M | $450.0M | +7,230 (+0.4%) | August 31, 2026 |
| 6 | State Street® SPDR® S&P 500® ETF | 1.26% | 1.8M | $422.9M | — | September 30, 2026 |
| 7 | First Trust Rising Dividend Achiev ETF | 1.16% | 1.6M | $390.8M | +2,827 (+0.2%) | September 30, 2026 |
| 8 | Vanguard MStar Growth Index Investor | 0.85% | 1.2M | $284.1M | −661,384 (−35.7%) | September 30, 2026 |
| 9 | Vanguard MStar Mid Cap Growth ETF | 0.81% | 1.1M | $270.6M | +18,139 (+1.6%) | September 30, 2026 |
| 10 | State Street®HlthCrSelSectSPDR®ETF | 0.73% | 1.0M | $244.4M | +3,184 (+0.3%) | September 30, 2026 |
| 11 | Invesco S&P 500® Equal Weight ETF | 0.63% | 890K | $212.8M | −1,805 (−0.2%) | September 30, 2026 |
| 12 | Vanguard Dividend Appreciation ETF | 0.58% | 816K | $195.0M | −4,979 (−0.6%) | September 30, 2026 |
| 13 | First Trust Capital Strength ETF | 0.55% | 767K | $183.4M | −487 (−0.1%) | September 30, 2026 |
| 14 | Vanguard Institutional Index I | 0.54% | 763K | $182.3M | −12,464 (−1.6%) | September 30, 2026 |
| 15 | iShares US Medical Devices ETF | 0.50% | 708K | $169.1M | +12,384 (+1.8%) | September 30, 2026 |
| 16 | Vanguard MStar Value Index Investor | 0.49% | 687K | $164.2M | +687,092 (0.0%) | September 30, 2026 |
| 17 | iShares Russell Mid-Cap ETF | 0.43% | 600K | $143.5M | +1,102 (+0.2%) | September 30, 2026 |
| 18 | Fidelity Mid Cap Index | 0.39% | 553K | $132.1M | +2,397 (+0.4%) | August 31, 2026 |
| 19 | Folksam LO Världen | 0.36% | 510K | $121.9M | — | September 30, 2026 |
| 20 | Fidelity SAI US Quality Index | 0.36% | 507K | $121.1M | +2,161 (+0.4%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
RMD insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-07 | Michael J Farrell | Sell | $225.50 | 4,991 | $1.1M |
| 2026-04-01 | Peter C Farrell | Sell | $225.00 | 2,000 | $450,000 |
| 2026-03-30 | Ro Khanna | Sell | $220.26 | — | — |
| 2026-03-23 | Ro Khanna | Sell | $228.19 | — | — |
| 2026-03-09 | Michael J Farrell | Sell | $251.03 | 4,991 | $1.3M |
| 2026-03-04 | Peter C Farrell | Sell | $260.22 | 2,000 | $520,440 |
| 2026-02-24 | Ro Khanna | Buy | $251.72 | — | — |
| 2026-02-09 | Michael J Farrell | Sell | $273.78 | 4,991 | $1.4M |
| 2026-02-04 | Michael J Rider | Sell | $260.00 | 50 | $13,000 |
| 2026-02-04 | Peter C Farrell | Sell | $251.31 | 2,000 | $502,620 |
| 2026-01-29 | Ro Khanna | Sell | $257.83 | — | — |
| 2026-01-23 | Ro Khanna | Sell | $252.44 | — | — |
| 2026-01-07 | Michael J Farrell | Sell | $248.46 | 4,991 | $1.2M |
| 2026-01-07 | Peter C Farrell | Sell | $248.83 | 2,000 | $497,660 |
| 2026-01-02 | Michael J Rider | Sell | $241.75 | 50 | $12,088 |
| 2025-12-03 | Peter C Farrell | Sell | $251.47 | 2,000 | $502,940 |
| 2025-11-25 | Witte Jan De | Sell | $255.00 | 2,055 | $524,025 |
| 2025-11-12 | Peter C Farrell | Sell | $252.05 | 2,000 | $504,100 |
| 2025-11-11 | Witte Jan De | Sell | $250.25 | 487 | $121,872 |
| 2025-11-07 | Michael J Farrell | Sell | $249.75 | 8,011 | $2.0M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
RMD shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns RMD
Institutional investors own 73.0% of ResMed's shares and insiders 0.51%. The largest holder is BlackRock Inc with 8.76% of the shares (12.3M), as of June 30, 2026. Among the top 20 institutions, 13 added shares and 7 reduced their stake in the latest filings. Short interest is 9.13% of the float, or 10.02 days of average trading volume. The share count rose 3.4% since 2014.
Related: RMD analyst forecast, RMD key metrics, RMD dividend history. See the RMD stock overview for the latest quote and news.
RMD ownership FAQ
Who owns the most ResMed stock?
The largest shareholders of ResMed are BlackRock Inc (8.76%), Vanguard Capital Management, LLC (6.74%), Vanguard Portfolio Management, LLC (5.63%), State Street Corp (4.75%), Geode Capital Management, LLC (3.09%).
What percentage of ResMed is owned by institutions?
Institutions hold 73.0% of ResMed's shares outstanding; insiders hold 0.51%.
Which funds own ResMed?
The largest fund holders of ResMed are Vanguard MStar Total Stk Mkt Idx Invest (3.28%), Vanguard 500 Index Investor (2.69%), Vanguard MStar Mid Cap Index Instl (2.20%), iShares Core S&P 500 ETF (1.37%), Fidelity 500 Index (1.34%).
What is ResMed's short interest?
12.8M shares of ResMed were sold short, 9.13% of the float; at the average daily volume it would take 10.02 days to cover.
Are insiders buying or selling ResMed?
Of the latest 20 reported insider transactions in ResMed (since November 7, 2025), 1 were purchases and 19 were sales.
How many shares of ResMed are outstanding?
ResMed has 140.6M shares outstanding, of which 143.3M are in the public float.